Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

sleep apnoea

  • Home
  •  
  • sleep apnoea



  • Most Read
  • Latest Comments
  • Compumedics sees 74% sales growth driven by sales in China
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Compumedics sees 74% sales growth driven by sales in China
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • Compumedics sees 74% sales growth driven by sales in China
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • Compumedics sees 74% sales growth driven by sales in China
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • Compumedics sees 74% sales growth driven by sales in China
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • Knosys secures contract from WA Office of Public Prosecutions for document management tech
    Knosys secures contract from WA Office of Public Prosecutions for document management tech
    • News

  • Compumedic hits record medtech diagnostics revenue with growth in US and China being targeted
    Compumedic hits record medtech diagnostics revenue with growth in US and China being targeted
    • News

  • InteliCare expands aged care pilot program to full site deployment in $2.1m contract win
    InteliCare expands aged care pilot program to full site deployment in $2.1m contract win
    • News

  • Orcoda’s Future Fleet bags new sales orders exceeding $640k in six weeks
    Orcoda’s Future Fleet bags new sales orders exceeding $640k in six weeks
    • News

  • Spectur records highest revenue month in company history in December, reduced debt while swinging deals
    Spectur records highest revenue month in company history in December, reduced debt while swinging deals
    • News

  • Compumedics sees 74% sales growth driven by sales in China
    • News

    Compumedics sees 74% sales growth driven by sales in China

    Medical device company Compumedics (ASX: CMP) has reported an impressive surge in sales, projecting a revenue of $26 million for H1 FY24. This marks a major 35% increase compared to H1 FY23. The performance is attributed to key factors including the Company’s second MEG sale to Tianjin Normal University (TJNU) in China and successful initial

    Read More
    Public
  • Bigger fish: ResApp to be acquired by pharma giant Pfizer
    • News

    Bigger fish: ResApp to be acquired by pharma giant Pfizer

    It’s not a question of AstraZeneca or Pfizer for digital health company ResApp Health (ASX: RAP) who have today entered into a binding scheme implementation deed to be acquired by pharmaceutical giant, Pfizer. Yes, one of the world’s biggest pharma companies has been perusing the ASX for a small homegrown biotech to snap up, we’re

    Read More
    Public
  • How Incannex is helping you catch some zzz’s
    • News

    How Incannex is helping you catch some zzz’s

    Unsurprisingly, four out of ten adults experience regular poor sleep. We all know the consequences of a bad night’s rest on our health, performance and mood, as well as the crippling caffeine addiction that develops. *Sips double shot oat milk latte*  People with Obstructive Sleep Apnoea (OSA) have it worse. OSA is characterised by partial

    Read More
    Public
  • ResApp’s sleep apnoea app now available on Apple App Store
    • News

    ResApp’s sleep apnoea app now available on Apple App Store

    Australians that are struggling to get a good night sleep can now screen their likelihood of suffering from sleep apnoea with medtech company ResApp Health (ASX: RAP) having launched their clinically tested SleepCheck app on the iPhone App Store.  By downloading the smartphone app, SleepCheck can record and analyse breaking and snorting sounds during sleep

    Read More
    Public
  • ResApp to launch wireless Sleep Apnoea diagnostics app
    • News

    ResApp to launch wireless Sleep Apnoea diagnostics app

    Australian medtech company ResApp (ASX: RAP) is set to make diagnosing sleep apnoea significantly easier for individuals with the launch of the SleepCheck smartphone app which has been clinically tested.  Obstructive sleep apnoea (OSA) is one of the most common sleep breathing disorders which affects around 30%of men and 20%of women. However, studies show that

    Read More
    Public
  • Oventus secure national distributor in the United States for sleep apnoea treatment
    • News

    Oventus secure national distributor in the United States for sleep apnoea treatment

    Australian medtech company Oventus (ASX: OVN) is surging ahead with its plans to expand into the United States, having reached an agreement with healthcare provider Aeroflow Healthcare for Oventus’ Sleep Treatment Platform and consumables.  The partnership will see Aeroflow offer Oventus products under subcontracts which will initially be introduced in the Southeastern States before being

    Read More
    Public

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.